Thalidomide-NH-PEG4-Ms

发表于由

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白，专注于信号通路和疾病研究领域。

Thalidomide-NH-PEG4-Ms 

Thalidomide-NH-PEG4-Ms 是一种 E3 连接酶配体-linker 偶联物 (E3 ligase ligand-linker conjugate)，包含基于 Thalidomide 的 cereblon 配体和 1 个 linker。用于合成 PROTAC BCL-XL 降解剂 XZ739。

Thalidomide-NH-PEG4-Ms

Thalidomide-NH-PEG4-Ms Chemical Structure

CAS No. : 2140807-24-3

规格 是否有货
100 mg   询价  
250 mg   询价  
500 mg   询价  

* Please select Quantity before adding items.

生物活性

Thalidomide-NH-PEG4-Ms is an E3 ligase ligand-linker conjugate that incorporates Thalidomide based cereblon ligand and a linker used for PROTAC BCL-XL degrader XZ739[1].

IC50 & Target

Cereblon

 

体外研究
(In Vitro)

XZ739, a CRBN-dependent PROTAC BCL-XL degrader with a DC50 value of 2.5 nM in MOLT-4 cells after 16 h treatment. XZ739 also induces cell death through caspase-mediated apoptosis[1].

Shanghai Jinpan Biotech Co Ltd has not independently confirmed the accuracy of these methods. They are for reference only.
分子量

527.54

Formula

C22H29N3O10S
CAS 号

2140807-24-3
运输条件

Room temperature in continental US; may vary elsewhere.
储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.
参考文献

  • [1]. Xuan Zhang,et al. Discovery of PROTAC BCL-X L Degraders as Potent Anticancer Agents With Low On-Target Platelet Toxicity. Eur J Med Chem. 2020 Apr 15;192:112186.

所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务